Siolta Therapeutics

Homer is a UCSF professor of medicine and principal investigator for its Asthma Clinical Research Center. He trained in pulmonary medicine at Oxford University and UCSF, published nearly 100 articles, and participated in clinical trials of asthma therapeutics.

Nikole is a founder and lead executive at Siolta, where Nikole leads a team with expertise in microbiology, immunology, and bioinformatics. Nikole has over a decade of experience in microbial ecology and host/microbe interactions.

Peter, a former FDA chief counsel and senior counsel at Covington and Burling LLP, teaches food and drug law at Harvard Law School. He has represented national industry trade associations and works on FDA legislation.

Khosla Ventures founding partner Samir has nearly 20 years’ experience growing early-stage life sciences, health, sustainability, and biotechnology companies. He began in genomic sciences at TIGR and has invested in, started, developed, or led over 50 companies.

The company uses its understanding of the human microbiome, microbe-body interactions, and anaerobic microbiology to create live biotherapeutic products aimed at preventing diseases in mothers and infants, including atopic diseases, women’s health issues, and rare pediatric diseases.

Located inside MBC Bio Labs, the Bay Area's premier life science incubators.

Siolta Therapeutics is a clinical-stage company developing live biotherapeutics that target the core drivers of disease.

The page says the site collects comment-form data, visitors’ IP addresses, and browser user-agent strings for spam detection.